KIZOO Technology Capital

Reservoir Neuroscience, Inc. is a biopharmaceutical company focused on developing innovative therapeutics aimed at repairing the blood-brain barrier and restoring vascular function in the brain. Founded in 2019 and based in Emeryville, California, the company targets neurological disorders, including Alzheimer's disease, by addressing dysfunctional blood vessels in the brain. Its therapeutics are designed to improve cognitive function and enhance disease outcomes for patients suffering from age-related cognitive impairment and other neurological conditions.

Cellvie develops mitochondria-based therapeutics designed to restore cellular bioenergetics and improve organ function. The company uses isolated mitochondria derived from donor cells delivered by infusion to repair damaged or energy-depleted cells and address conditions linked to mitochondrial dysfunction. By transplanting viable mitochondria into compromised cells, Cellvie aims to interrupt the cellular damage cascade associated with ischemia-reperfusion injury, a common factor in heart attacks and related conditions, enabling affected cells to resume energy production and support tissue recovery, with a focus on high-energy-demand tissues where mitochondrial function is critical.

Mogling Bio is a biotechnology firm focused on developing innovative pharmacological approaches to rejuvenate aging stem cells, particularly within the hematopoietic system. The company's primary strategy involves inhibiting the elevated activity of Cdc42, a process that aims to restore the functionality of old stem cells. This rejuvenation has the potential to improve the production of blood and immune cells, providing new treatment options for patients suffering from leukemia and other blood disorders. By addressing the underlying causes of these conditions, Mogling Bio endeavors to strengthen patients' immune systems and enhance their overall health outcomes.

Elastrin Therapeutics is a biotechnology startup dedicated to improving health by restoring damaged and hardened tissues to their natural resilience. The company focuses on developing innovative therapeutics that target and reverse the calcification and hardening of arteries, as well as inflammatory tissue damage in conditions such as arterial and lung diseases. Elastrin's proprietary platform combines particle design with elastin targeting to enhance drug efficacy and eliminate side effects, aiming to provide effective treatments for life-threatening illnesses.

Revel Pharmaceuticals develops therapeutic enzymes designed to degrade molecular damage associated with aging. Its primary focus is on creating treatments for age-related conditions such as osteoarthritis, kidney disease, cardiovascular disease, skin aging, and diabetes complications.

Underdog Pharmaceuticals, Inc. is a biotechnology company focused on developing regenerative medicine and direct interventions to address age-related diseases. Founded in 2019 and based in Mountain View, California, the company aims to target toxic forms of cholesterol with its innovative products. These treatments provide potential solutions for conditions such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. Underdog Pharmaceuticals utilizes rationally designed molecules and novel derivatives of established compounds to create disease-modifying therapies, reflecting a new perspective on cardiovascular health influenced by the SENS Research Foundation. Through its research and product development, the company seeks to treat the underlying causes of age-related diseases rather than merely addressing their symptoms.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Elastrin Therapeutics is a biotechnology startup dedicated to improving health by restoring damaged and hardened tissues to their natural resilience. The company focuses on developing innovative therapeutics that target and reverse the calcification and hardening of arteries, as well as inflammatory tissue damage in conditions such as arterial and lung diseases. Elastrin's proprietary platform combines particle design with elastin targeting to enhance drug efficacy and eliminate side effects, aiming to provide effective treatments for life-threatening illnesses.

Cellvie develops mitochondria-based therapeutics designed to restore cellular bioenergetics and improve organ function. The company uses isolated mitochondria derived from donor cells delivered by infusion to repair damaged or energy-depleted cells and address conditions linked to mitochondrial dysfunction. By transplanting viable mitochondria into compromised cells, Cellvie aims to interrupt the cellular damage cascade associated with ischemia-reperfusion injury, a common factor in heart attacks and related conditions, enabling affected cells to resume energy production and support tissue recovery, with a focus on high-energy-demand tissues where mitochondrial function is critical.

Founded in 2017, Elevian is a biotechnology company dedicated to developing regenerative medicines. It focuses on restoring the body's natural repair mechanisms to prevent and treat age-related diseases such as stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Underdog Pharmaceuticals, Inc. is a biotechnology company focused on developing regenerative medicine and direct interventions to address age-related diseases. Founded in 2019 and based in Mountain View, California, the company aims to target toxic forms of cholesterol with its innovative products. These treatments provide potential solutions for conditions such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. Underdog Pharmaceuticals utilizes rationally designed molecules and novel derivatives of established compounds to create disease-modifying therapies, reflecting a new perspective on cardiovascular health influenced by the SENS Research Foundation. Through its research and product development, the company seeks to treat the underlying causes of age-related diseases rather than merely addressing their symptoms.

MAIA Biotechnology is a biopharmaceutical company focused on developing targeted immunotherapies for cancer. Its lead asset, THIO, is an investigational drug candidate that targets telomeres and enhances immune response.

Founded in London in 2016, LIfT BioSciences develops a proprietary platform for allogeneic innate immuno-cell therapy. Its Neutrophil Only Leukocyte Infusion Therapy (N-LIfT®) enables scalable production of Immunomodulatory Alpha Neutrophils (IMAN®s) from induced pluripotent stem cells (iPSCs), offering potential mono or combo therapies.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Turn.bio is a biotechnology company developing drugs to reverse aging and age-related diseases. Utilizing its patented mRNA platform technology ERA, the company targets indications in immune-related diseases like cancer and dermatological conditions, as well as therapies for ophthalmology, osteoarthritis, and the muscular system.

MOQO is a cloud-based platform that enables various entities such as municipal utilities, real estate industries, companies, and clubs to offer shared mobility services. Its platform facilitates the integration of mobility services, providing clients access to a comprehensive shared mobility ecosystem.

FoxBio is a developer of a small molecules techniques intended to reduce senescent cells in human bodies. The company's techniques targets the pro-survival pathways of senescent cells to remove them from the body, enabling patients to have multiple health benefits and delay the onset of age related diseases.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Founded in 2017, Elevian is a biotechnology company dedicated to developing regenerative medicines. It focuses on restoring the body's natural repair mechanisms to prevent and treat age-related diseases such as stroke recovery, Alzheimer's disease, coronary artery disease, and Type 2 diabetes.

shyftplan GmbH is a Berlin-based company that specializes in developing software solutions for the human resources industry. Founded in 2012, the company offers a comprehensive SaaS platform focused on employee management and communication. Its core offerings include scheduling, absence management, time tracking, HR management, and payroll services. The platform enables HR managers to efficiently set up and manage shift plans by assigning employees to specific shifts based on their competencies. Additionally, shyftplan enhances workforce management by integrating employee intelligence and facilitating communication between non-desk workers and their work environments. This holistic approach streamlines personnel planning and optimizes operational efficiencies for organizations.

Antoxerene, Inc. is an intellectual property holding company focused on small molecule drug discovery, particularly in relation to aging pathways. Established in 2016 and based in Lafayette, New York, the company operates a unique drug discovery platform that employs patent-pending production technology. This technology facilitates the manufacturing of challenging protein targets in their biologically active forms at scale. Antoxerene aims to identify and develop small molecule drugs that target critical protein-drug and protein-protein interactions, with a particular focus on selectively eliminating toxic senescent cells to restore tissue function. The company actively seeks collaborations with industry and academic partners who share its commitment to advancing next-generation therapies for age-related illnesses.

AgeX Therapeutics, Inc. is a biotechnology company based in Alameda, California, specializing in the development and commercialization of innovative therapeutics aimed at addressing human aging and degenerative diseases. The company harnesses proprietary technologies, including telomerase-mediated cell immortality and induced Tissue Regeneration, to create novel treatments. Its product pipeline features two primary cell-based candidates: AGEX-BAT1, which targets age-related metabolic disorders such as Type II diabetes, and AGEX-VASC1, designed to restore vascular support in ischemic tissues. Additionally, AgeX is working on AGEX-iTR1547, a drug formulation intended to enhance regenerative potential in aged tissues suffering from degenerative conditions. The company also offers human embryonic stem cells and a suite of genomic interpretation tools for researchers. AgeX has collaborated with the University of California, Irvine, on neural stem cell research related to Huntington's disease and other neurological disorders. Founded in 2017, AgeX continues to advance its mission of addressing the challenges associated with aging.

CellAge is a biotechnology company focused on developing innovative tools and therapies aimed at identifying and eliminating aged cells. By leveraging synthetic biology, the company creates advanced methods for targeting senescent cells, which are implicated in various age-related diseases such as osteoarthritis and atherosclerosis. CellAge's mission is to enhance the quality of life for the aging population, enabling individuals to experience their later years with the health and vitality typically associated with youth. Through its research and product development, CellAge aspires to contribute to a future where age-related diseases are significantly diminished, allowing people to enjoy more time with their loved ones.

Lysoclear, Inc. is a biotechnology company based in Lafayette, New York, focused on developing enzyme therapies for eye diseases. Established in 2016, the company aims to create innovative treatments for conditions such as age-related macular degeneration (AMD) and Stargardt’s macular degeneration. Lysoclear is also engaged in developing therapies for lysosomal storage diseases, which arise from defects in endogenous lysosomal enzymes. Currently in the pre-clinical stage, the company's research targets atrophic "dry" AMD and seeks to address significant unmet medical needs in the field of ophthalmology.

MOQO is a cloud-based platform that enables various entities such as municipal utilities, real estate industries, companies, and clubs to offer shared mobility services. Its platform facilitates the integration of mobility services, providing clients access to a comprehensive shared mobility ecosystem.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Ichor Therapeutics, Inc. is a pre-clinical biotechnology company located in Syracuse, NY. The company has several intramural research programs that broadly focus on therapeutic interventions for age-related disease. Ichor is also involved in several smaller ventures aimed at reducing the barriers to entry for biotechnology entrepreneurs and independent scientists.

SuitePad GmbH is a Berlin-based company specializing in tablet-based communication solutions for the hospitality industry. Founded in 2012, the company aims to enhance the guest experience by integrating various services into a single device. Its tablets serve as a comprehensive platform for hotel guests, providing essential information about the hotel and its surroundings, while facilitating direct bookings for services such as room service and wellness appointments. SuitePad has successfully collaborated with both private and chain hotels across Germany, Austria, and Switzerland to ensure its product meets the specific needs of its clients. Since its first installation in 2013, SuitePad has expanded its presence to 11 European countries and has received multiple industry awards, including the CeBit BITKOM Innovation Award and the HSMAI Technology and Innovation Award, for its innovative contributions to hotel guest communication.

Mambu is a SaaS (Software as a Service) company that develops a cloud-based core banking platform. It enables financial institutions, including banks, fintech startups, and microfinance institutions, to manage credit and deposit products more efficiently. Mambu's platform simplifies credit risk assessment, loan lifecycle tracking, and portfolio management. It also streamlines internal workflows, improves data quality, and reduces fraud risk. With a presence in multiple countries, Mambu serves over 200 clients globally, helping them build modern digital financial products faster, securely, and cost-effectively.

Staffbase is a company that specializes in enhancing employee communication through its comprehensive Communications Cloud platform. The platform is designed for large and international organizations across various sectors, including manufacturing, healthcare, logistics, automotive, retail, and energy. It enables employers to securely engage with their workforce, ensuring that employees have easy access to relevant corporate information and digital workplace tools, including existing intranets. With a focus on mobile compatibility, Staffbase's solutions allow companies to effectively connect with their employees, regardless of their location, whether in the office, at home, or on the factory floor. Serving over 2,500 leading organizations worldwide, Staffbase is dedicated to transforming the way companies communicate with their employees.

Prescreen International, established in 2011 and headquartered in Munich, Germany, specializes in developing and operating a cloud-based e-recruitment platform and applicant tracking system. The company streamlines recruitment processes by enabling businesses to publish job vacancies online and offline, collect applications, analyze data, and evaluate candidates efficiently. As of 2017, Prescreen operates as a subsidiary of XING AG.

Oisin Biotechnologies, Inc. is a biotechnology company based in Seattle, Washington, established in 2014, that specializes in developing therapies aimed at addressing age-related diseases through the elimination of senescent cells. The company utilizes a proprietary technology platform known as SENSOlytics, which enables the precise targeting of senescent cells based on their DNA expression, distinguishing them from healthy cells. Oisin Biotechnologies is advancing a range of interventions, including a lead program that targets frailty by promoting muscle growth independent of exercise and another that selectively eliminates fat cells. The company's innovative approach employs a non-viral delivery system, facilitating the effective distribution of DNA and RNA-based therapies to combat various age-related conditions. Research indicates that the clearance of senescent cells not only mitigates the adverse effects of aging but may also extend lifespan and enhance overall health.

shyftplan GmbH is a Berlin-based company that specializes in developing software solutions for the human resources industry. Founded in 2012, the company offers a comprehensive SaaS platform focused on employee management and communication. Its core offerings include scheduling, absence management, time tracking, HR management, and payroll services. The platform enables HR managers to efficiently set up and manage shift plans by assigning employees to specific shifts based on their competencies. Additionally, shyftplan enhances workforce management by integrating employee intelligence and facilitating communication between non-desk workers and their work environments. This holistic approach streamlines personnel planning and optimizes operational efficiencies for organizations.

Mambu is a SaaS (Software as a Service) company that develops a cloud-based core banking platform. It enables financial institutions, including banks, fintech startups, and microfinance institutions, to manage credit and deposit products more efficiently. Mambu's platform simplifies credit risk assessment, loan lifecycle tracking, and portfolio management. It also streamlines internal workflows, improves data quality, and reduces fraud risk. With a presence in multiple countries, Mambu serves over 200 clients globally, helping them build modern digital financial products faster, securely, and cost-effectively.

SuitePad GmbH is a Berlin-based company specializing in tablet-based communication solutions for the hospitality industry. Founded in 2012, the company aims to enhance the guest experience by integrating various services into a single device. Its tablets serve as a comprehensive platform for hotel guests, providing essential information about the hotel and its surroundings, while facilitating direct bookings for services such as room service and wellness appointments. SuitePad has successfully collaborated with both private and chain hotels across Germany, Austria, and Switzerland to ensure its product meets the specific needs of its clients. Since its first installation in 2013, SuitePad has expanded its presence to 11 European countries and has received multiple industry awards, including the CeBit BITKOM Innovation Award and the HSMAI Technology and Innovation Award, for its innovative contributions to hotel guest communication.

Babbel operates an ecosystem of online language learning experiences aimed at enabling mutual understanding through language. Its offerings include the Babbel app, Babbel Live, podcasts and Babbel for Business, providing lessons, live online classes and real-world practice across 14 languages. The platform features more than 60,000 lessons hand-crafted by nearly 200 linguists and language experts, with content continually refined based on user behavior. Lessons sync across desktop, mobile and tablet and incorporate speech-recognition technology to support accurate pronunciation. Babbel combines human expertise with technology to deliver adaptive, interactive content through courses, games, videos and live sessions, helping users learn anytime, anywhere. The company employs about 1,000 people from more than 80 nationalities, with headquarters in Berlin and a U.S. office in New York. Babbel has sold over 16 million subscriptions, reflecting its reach in helping people learn new languages for real-world use.

Mambu is a SaaS (Software as a Service) company that develops a cloud-based core banking platform. It enables financial institutions, including banks, fintech startups, and microfinance institutions, to manage credit and deposit products more efficiently. Mambu's platform simplifies credit risk assessment, loan lifecycle tracking, and portfolio management. It also streamlines internal workflows, improves data quality, and reduces fraud risk. With a presence in multiple countries, Mambu serves over 200 clients globally, helping them build modern digital financial products faster, securely, and cost-effectively.

Hipaway operates an online platform facilitating hotel bookings exclusively within Germany.

Hojoki is a team collaboration application that integrates various cloud services to streamline workflow and communication. It enables users to consolidate notifications from multiple platforms, allowing for real-time discussion and updates related to ongoing projects. The application supports a wide range of cloud tools, including Google Docs, Dropbox, Evernote, and GitHub, among others. By bringing together these disparate applications, Hojoki enhances productivity and facilitates seamless teamwork.

Hojoki is a team collaboration application that integrates various cloud services to streamline workflow and communication. It enables users to consolidate notifications from multiple platforms, allowing for real-time discussion and updates related to ongoing projects. The application supports a wide range of cloud tools, including Google Docs, Dropbox, Evernote, and GitHub, among others. By bringing together these disparate applications, Hojoki enhances productivity and facilitates seamless teamwork.

Tamyca GmbH is a mobility platform provider that operates a leading peer-to-peer carsharing marketplace in Germany, known as Tamyca - take my car, which launched in November 2010. The platform enables car owners to list their idle vehicles for rent, allowing them to earn extra income by setting their own prices and availability. Users seeking access to a vehicle can conveniently find options in their neighborhood through a smartphone app or web service, achieving cost savings of up to 60% compared to traditional car rental and carsharing services. Tamyca also offers additional solutions based on onboard systems, booking software, and operational support, enhancing the overall user experience in the car-sharing ecosystem.

Pactas provides a SaaS platform for recurring billing and subscription management for SaaS and subscription companies, no matter you are a startup or a well established business. Follow us: @pactashq on Twitter | pactas on Facebook

Advertory GmbH, established in Berlin, Germany, in 2010 by a German-French team, specializes in providing an online marketing platform tailored for small and mid-sized businesses. The company offers user-friendly tools to create and maintain an effective web presence, integrated with local search offerings and mobile versions to attract new customers. Their primary clientele includes freelancers, service providers, craftsmen, and restaurants. Advertory's platform aims to help these businesses compete online, monitor performance, and retain customers efficiently, even with limited time for website management.

MegaZebra GmbH is a Munich-based developer and publisher of casual online games, established in 2008. The company specializes in creating engaging games for social network communities worldwide, with titles such as Solitaire Castle, Mahjong Trails, Mahjong, Nuzzle Puzzle, and Sudoku. MegaZebra's games are designed to be playable across various platforms, allowing users to connect and play with friends and family on social networks, including integration with Facebook. The company is backed by a seasoned team of professionals, enhancing its capabilities in the competitive online gaming market.

Mambu is a SaaS (Software as a Service) company that develops a cloud-based core banking platform. It enables financial institutions, including banks, fintech startups, and microfinance institutions, to manage credit and deposit products more efficiently. Mambu's platform simplifies credit risk assessment, loan lifecycle tracking, and portfolio management. It also streamlines internal workflows, improves data quality, and reduces fraud risk. With a presence in multiple countries, Mambu serves over 200 clients globally, helping them build modern digital financial products faster, securely, and cost-effectively.

MegaZebra GmbH is a Munich-based developer and publisher of casual online games, established in 2008. The company specializes in creating engaging games for social network communities worldwide, with titles such as Solitaire Castle, Mahjong Trails, Mahjong, Nuzzle Puzzle, and Sudoku. MegaZebra's games are designed to be playable across various platforms, allowing users to connect and play with friends and family on social networks, including integration with Facebook. The company is backed by a seasoned team of professionals, enhancing its capabilities in the competitive online gaming market.

Babbel operates an ecosystem of online language learning experiences aimed at enabling mutual understanding through language. Its offerings include the Babbel app, Babbel Live, podcasts and Babbel for Business, providing lessons, live online classes and real-world practice across 14 languages. The platform features more than 60,000 lessons hand-crafted by nearly 200 linguists and language experts, with content continually refined based on user behavior. Lessons sync across desktop, mobile and tablet and incorporate speech-recognition technology to support accurate pronunciation. Babbel combines human expertise with technology to deliver adaptive, interactive content through courses, games, videos and live sessions, helping users learn anytime, anywhere. The company employs about 1,000 people from more than 80 nationalities, with headquarters in Berlin and a U.S. office in New York. Babbel has sold over 16 million subscriptions, reflecting its reach in helping people learn new languages for real-world use.